UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009691
Receipt number R000011279
Scientific Title Phase II trial of formula diet for gastric cancer surgery with obesity
Date of disclosure of the study information 2013/01/10
Last modified on 2019/07/20 08:35:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II trial of formula diet for gastric cancer surgery with obesity

Acronym

Phase II trial of formula diet for gastric cancer surgery with obesity

Scientific Title

Phase II trial of formula diet for gastric cancer surgery with obesity

Scientific Title:Acronym

Phase II trial of formula diet for gastric cancer surgery with obesity

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Efficacy and safety of formula diet for gastric cancer surgery with obesity

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Weight loss rate

Key secondary outcomes

Body composition
Laboratory data
Operative time
Blood loss
Morbidity


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Formula diet

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with histrogically proven gastric cancer
Potentially resectable
BMI >> 25
Waist measurement >> 85cm for male
Waist measurement >> 90cm for female

Key exclusion criteria

Allergy for a soybean, milk, an egg, a peanut, and gelatin
Active infection
Uncontrolled diabetes

Target sample size

33


Research contact person

Name of lead principal investigator

1st name Kentaro
Middle name
Last name Inoue

Organization

Kansai Medical University

Division name

Surgery

Zip code

573-1191

Address

Shinmachi 2-3-1 Hirakata Osaka Japan

TEL

072-804-0101

Email

inoueke@hirakata.kmu.ac.jp


Public contact

Name of contact person

1st name Kentaro
Middle name
Last name Inoue

Organization

Kansai Medical University

Division name

Surgery

Zip code

573-1191

Address

Shinmachi 2-3-1 Hirakata Osaka Japan

TEL

072-804-0101

Homepage URL


Email

inoueke@hirakata.kmu.ac.jp


Sponsor or person

Institute

Department of surgery, Kansai Medical University

Institute

Department

Personal name



Funding Source

Organization

Department of surgery, Kansai Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Medical University Hospital

Address

Shinmachi 2-3-1 Hirakata Osaka Japan

Tel

072-804-0101

Email

inoueke@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関西医科大学附属枚方病院


Other administrative information

Date of disclosure of the study information

2013 Year 01 Month 10 Day


Related information

URL releasing protocol

https://www.ncbi.nlm.nih.gov/pubmed/29575594

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/29575594

Number of participants that the trial has enrolled

33

Results

RESULTS:
Thirty-three patients were enrolled from September 2013 to August 2015. The patients achieved a mean weight loss of 4.5% (95% confidence interval [CI]: 3.8-5.1), corresponding to 3.2?kg (95%CI: 2.7-3.7?kg). Body fat mass was significantly decreased by a mean of 2.5 kg (95%CI: 1.9-3.1), whereas skeletal muscle mass was unaffected (mean: -0.20 kg [95%CI: -0.55-0.15]). The visceral fat mass reduction rate was high as 16.8% (range, 11.6%-22.0%).

Results date posted

2019 Year 07 Month 20 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

patients with obesity who were planning to undergo laparoscopic gastrectomy for gastric cancer. Obesity was defined according to the Japanese criteria: BMI >>25kg/m2 or waist circumference >>85?cm in men and >>90cm in women.

Participant flow

The patients underwent a preoperative 20-day very low-calorie diet and received nutritional counseling.

Adverse events

Hiatal hernia 1 case

Outcome measures

Preoperative weight loss

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 12 Month 23 Day

Date of IRB

2013 Year 03 Month 07 Day

Anticipated trial start date

2013 Year 04 Month 01 Day

Last follow-up date

2016 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 01 Month 04 Day

Last modified on

2019 Year 07 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011279


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name